Views: 1 创始人: Site Editor Publish Time: 2025-07-03 Origin: Site
Inquire
TB-500 (Thymosin Beta-4)
A synthetic version of the natural peptide thymosin β₄, involved in cell migration, tissue repair, and angiogenesis.
Key actions: Reduces inflammation, promotes collagen deposition, and accelerates wound healing.
BPC-157 (Body Protecting Compound-157)
A synthetic peptide derived from human gastric juice protein.
Key actions: Enhances tissue regeneration (tendons, ligaments, GI tract), modulates inflammation, and protects against organ damage.
The blend aims to combine complementary mechanisms:
Accelerated Healing: TB-500’s cell migration + BPC-157’s angiogenic effects.
Anti-Inflammation: Both peptides suppress pro-inflammatory cytokines (e.g., TNF-α).
Tissue Protection: BPC-157 stabilizes endothelial barriers; TB-500 reduces oxidative stress.
Note: No clinical trials exist for this specific blend. Evidence is preclinical (animal/isolated tissue studies).
Reported applications (primarily in sports/regenerative medicine communities):
Musculoskeletal Injuries: Tendon tears, joint sprains, muscle strains.
Post-Surgical Recovery: Enhanced wound closure and reduced scarring.
Gut Health: BPC-157’s role in intestinal barrier repair.
Neuroprotection: Emerging research on nerve regeneration (animal models).
Consult a physician: Especially for underlying conditions (cancer, autoimmune disorders).
Source verification: Use ISO-certified labs to avoid contaminants.
Dosing: Anecdotal protocols vary widely (e.g., 250–500 mcg/day per peptide); no established guidelines exist.
Alternatives: Evidence-supported options (e.g., PRP, physical therapy) should be prioritized.